The Use of “Acellbia”—A Biosimilar of Rituximab in Systemic Sclerosis by Ananyeva, L. P., Garzanova, L. A., Desinova, O. V., Shayakhmetova, R. U., Starovoitova, M. N., Koneva, O. A., Ovsyannikova, O. B., Glukhova, S. I., Nasonov, E. L.

Get full text

Safety and Tolerability of Rituximab in the Treatment of Systemic Sclerosis by Garzanova, L. A., Ananyeva, L. P., Koneva, O. A., Desinova, O. V., Starovoytova, M. N., Ovsyannikova, O. B., Shayakhmetova, R. U., Glukhova, S. I.

Get full text

Erratum to: Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis by Ananyeva, L. P., Garzanova, L. A., Koneva, O. A., Starovoytova, M. N., Desinova, O. V., Ovsyannikova, O. B., Shayakhmetova, R. U., Cherkasova, M. V., Aleksankin, A. P., Nasonov, E. L.

Get full text

Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis by Ananyeva, L. P., Garzanova, L. A., Koneva, O. A., Starovoytova, M. N., Desinova, O. V., Ovsyannikova, O. B., Shayakhmetova, R. U., Cherkasova, M. V., Aleksankin, A. P., Nasonov, E. L.

Get full text

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis by Velauthapillai, A, Bootsma, M F R, Bruni, C, Bergmann, C, Matucci-Cerinic, M, Launay, D, Riemekastan, G, Garzanova, L, Airò, P, Rezus, E, da Silva, J A P, Del Galdo, F, Hunzelmann, N, Chung, L S, Krasowska, D, Distler, O, van den Ende, C H M, Vonk, M C

Get full text